Japanese jornal of Head and Neck Cancer
Online ISSN : 1883-9878
Print ISSN : 0911-4335
ISSN-L : 0911-4335
CONCOMITANT CHEMORADIOTHERAPY WITH CDDP AND 5FU FOR NASOPHARYNGEAL CARCINOMA
THE INITIAL EVALUATION AND SIDE EFFECTS
Yousuke TAKEUCHIHaruhiko SUZUKITakeo SHIGEHARAKen OMURAFumiyuki SHIMADAKazuo HATANOYuichi SEKIYATakashi TOGAWA
Author information
JOURNAL FREE ACCESS

1998 Volume 24 Issue 1 Pages 77-82

Details
Abstract
Concomitant chemoradiotherapy with CDDP and 5FU given to 18 patients with nasopharyngeal carcinoma during January 1994-October 1996. One and 17 were in Stages III-IV respectively. None had distant metastasis. The median duration of follow-up of all patients was 23.5 months (6-45). Objective responce (CR+PR) of the primary lesion and the regional nodes was 18/18 (100%), whereas CR was 2/18 (11%). CR+PR and CR at the primary lesion were 18/18 (100%) and 5/18 (28%) respectively. Two patients died of disease at T site. One patient was alive with disease. The remaining 15 (83%) patients were relapse free alive. There were 2 relapses, 1 at T+M, and 1 at T+N sites. Side effects, especially myelosuppression and mucositis, were severe. Leukopnia and mucositis in grade 3-4 were 78% and 89% respectively. In conclusion, this regimen has been effective in short term follow-up. However, because of severe side effects, further modifications are required. Long term follow-up are required to difine final effectiveness of this regimen.
Content from these authors
© Japan Society for Head and Neck Cancer
Previous article Next article
feedback
Top